Personal information

No personal information available

Activities

Collapse all

Works (3)

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

Nature
2023-01-26 | Journal article
DOI: 10.1038/s41586-022-05593-1
Contributors: Natasja L. de Vries; Joris van de Haar; Vivien Veninga; Myriam Chalabi; Marieke E. Ijsselsteijn; Manon van der Ploeg; Jitske van den Bulk; Dina Ruano; Jose G. van den Berg; John B. Haanen et al.
Source: check_circle
Crossref

γδ T cells are effectors of immune checkpoint blockade in mismatch repair-deficient colon cancers with antigen presentation defects

2021-10-15 | Other
DOI: 10.1101/2021.10.14.464229
Contributors: Natasja L. de Vries; Joris van de Haar; Vivien Veninga; Myriam Chalabi; Marieke E. Ijsselsteijn; Manon van der Ploeg; Jitske van den Bulk; Dina Ruano; John B. Haanen; Ton N. Schumacher et al.
Source: check_circle
Crossref

Tumor organoids: Opportunities and challenges to guide precision medicine

Cancer Cell
2021-09 | Journal article
DOI: 10.1016/j.ccell.2021.07.020
Contributors: Vivien Veninga; Emile E. Voest
Source: check_circle
Crossref
How many people are using ORCID?